Latest Breaking News On - Platform licensing business - Page 1 : comparemela.com

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJunshi biosciencesYuelei shenHansoh pharmaHaimen jiangsuChipscreen newway biosciencesDevelopment businessMerck kgaMerck kgaaBiocytogen pharmaceuticals beijing co ltdEco development businessProject integrumRona therapeuticsFully humanPlatform licensing business

Biocytogen Launches RenBiologics A SubBrand Focused on OutLicensing Fully Human Antibodies For Therapeutic Development

Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced the launch of a new subbrand RenBiologics to represent the companys antibody discovery business division.

San franciscoUnited statesHansoh pharmaJunshi biosciencesHaimen jiangsuYuelei shenChipscreen newway biosciencesMerck kgaDevelopment businessBiocytogen pharmaceuticals beijing co ltdMerck kgaaEco development businessProject integrumRona therapeuticsFully humanPlatform licensing business

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics

United statesNew yorkSan franciscoChipscreen newway biosciencesBarbara shecterJunshi biosciencesGabriel friedmanHansoh pharmaJoe oconnorHaimen jiangsuYuelei shenJoe oliverNational postBiocytogen pharmaceuticals beijing co ltdMerck kgaCanada revenue agency